The Underlying Mechanisms From Exercise-induced Muscle Damage on Force Loss
Trial Snapshot
- Phase
- Phase 1
- Status
- Terminated
- Sponsor
- University of Oklahoma
- Enrollment
- 3
- Locations
- 1
- Primary Endpoint
- change in maximal voluntary strength
Study Overview
Brief Summary
We have hypothesized: 1) Caffeine will increase maximal voluntary strength compared to placebo in undamaged muscle. 2) Caffeine will increase muscle activation compared to placebo in undamaged muscle. 3) Caffeine will enhance spinal excitability (indicated by an enhanced H-reflex) compared to placebo in undamaged muscle. 4) Caffeine will raise the pressure-pain threshold (indicating decreased pain sensitivity) in the calf muscle compared to placebo in undamaged muscle. 5) Caffeine will reduce the amount of low-frequency fatigue, indicated by an enhanced 20-100 hertz strength ratio, compared to placebo in undamaged muscle. 6) Caffeine will increase maximal voluntary strength compared to placebo in damaged muscle. 7) Caffeine will increase muscle activation compared to placebo in damaged muscle. 8) Caffeine will enhance spinal excitability (indicated by an enhanced H-reflex) compared to placebo in damaged muscle. 9) Caffeine will raise the pressure-pain threshold (indicating decreased pain sensitivity) in the calf muscle compared to placebo in damaged muscle. 10) Caffeine will reduce the amount of low-frequency fatigue, indicated by an enhanced 20-100 hertz strength ratio, compared to placebo in damaged muscle.
The proposed research will determine the effects of a 5mg/kg body weight dose of caffeine on muscular strength, activation, H-reflex function, and excitation-contraction coupling before and after exercise-induced muscle damage. The long term objectives are to gain a better understanding of caffeine and its affects following exercise-induced muscle damage allowing us to understand how caffeine is mechanistically interacting with functions of the body.
Detailed Description
A within participant, repeated measures experimental design will be used such that each participant will serve as his/her own control. Caffeine and placebo will be administered in a double-blind, counterbalanced manner. Caffeine and placebo (white flour) pills will be prepared by Kerri Tiedman or Jackie Straughn at the Doctors Park Pharmacy using an analytical balance. Anhydrous caffeine or white flour will be placed into opaque capsules. The pills will be placed into envelopes by Chris Black. He will then use a computer generated random number table to assign caffeine or placebo pills for each testing session in a counter-balanced fashion. The participant's identification number, as well as session number will be placed on the envelope. A spreadsheet containing only the participants' numbers and the testing condition will be kept by Chris Black until the study is complete. Jessica, Robby, Alex, Josh, and Jamie the research assistants, who will be blinded to the contents of the envelopes, will administer the pills to the participants and collect data from the participants. This will ensure the blinding of the researchers to the condition during data collection. Following the completion of data collection the spreadsheet will be given to all the above stated research assistants and the blinding will be broken for data analysis.
Total time commitment for the study will be approximately 10 hours over the course of 14 days. Three familiarization session and 5 testing sessions will be completed.
Test Day 1: - Potential participants will report to the sensory and muscle function lab for a 30 minute session involving the following:
D1.1 Written and verbal description of the experiment and all procedures will be given, and any questions will be answered. Informed consent will be completed.
D1.2 A physical activity readiness questionnaire (PAR-Q) will be completed (identifies contraindications to exercise.D1.3 A questionnaire screening for the potential adverse reactions to caffeine, current medication and supplements as well as an increased risk of rhabdomyolysis use will be competed. D1.4 Seated, resting blood pressure will be assessed in the right brachial artery. D1.5 Potential participants deemed eligible for the study will be asked to orally state to the researchers what they will be expected to do in the study and explain the risks and benefits of the study to confirm they understand the procedures, time commitment, freedom to withdraw, and risk and benefits of study participation. D1.6 Next, participants will practice the procedure for determining maximal voluntary isometric strength (MVC) of the plantar flexor muscle group. Participants will be seated in a specially designed chair with their hip at an angle of 90 degrees. A series of 3 maximal, all-out isometric contractions (contractions against a stationary object where the muscle does not shorten or lengthen) will be performed. Each contraction will last approximately 3 seconds. Participants will be given verbal encouragement throughout the contraction. Muscle activation (the amount or percentage of total muscle mass of the plantar flexors the person is able to use during a contraction) during the isometric contractions will be assessed using the interpolated-twitch technique (ITT). This technique involves applying an electrical current to the muscle via stimulation of the tibial motor axon (nerve) while it is contracting to determine if the muscle is able to generate any additional force, above and beyond what the participant can generate on their own. The force from this stimulation is compared to the force generated in a relaxed, non-contracting muscle to determine the percentage of the muscle the participant can active during a contraction. To perform the ITT stimulating electrodes are placed proximal to the patella and behind the knee over the tibial nerve. Participants will receive a brief (10 milliseconds) high intensity stimulation of the muscle during each contraction, and at 4 and 6 seconds following each contraction (while the muscle is relaxed). The MVC as well as the ITT will be determined in both the right and left calf.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Crossover
- Primary Purpose
- Basic Science
- Masking
- Double (Participant, Investigator)
Eligibility Criteria
- Ages
- 18 Years to 35 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •age range of 18-35 years of age
- •males and females who do not have a history of orthopedic injuries of the hip knee, and/or leg
- •Participants must be engaged in some form of physical activity on at least 3 days each week
Exclusion Criteria
- •An answer of "yes" to any of the seven questions on the physical activity readiness questionnaire (PAR-Q)
- •Average daily consumption of more than 40mg of caffeine per day as determined by the 2 week caffeine recall questionnaire
- •Use of any type of prescription psychiatric or prescription or over-the-counter pain medication
- •An answer of "yes" to questions 1,2,8, and 15-22 on the rhabdomyolysis screening questionnaire
- •An answer of "yes" on questions 3,4,6,7,8, 11,12, and 13 if the follow up information indicates any type of medication, drug, supplement, illness, and/or dietary need that could affect pain sensitivity or the risk of dehydration. Determinations will be made on a participant-by-participant basis depending on the answers provided
- •An answer of "yes" on question 24 indicating a previous adverse reaction to caffeine consumption
- •Resting systolic blood pressure >140 mmHg and/or resting diastolic blood pressure >90 mmHg
- •Pregnancy or suspicion of pregnancy.
Arms & Interventions
Caffeine Pill
The caffeine will be administered.
Intervention: Caffeine (Drug)
Placebo/Flour Pill
The flour will be administered.
Intervention: Flour (Other)
Outcomes
Primary Outcomes
change in maximal voluntary strength
Time Frame: Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol
Measure for maximal voluntary strength is in kilograms (kg) Change in maximal voluntary strength between base line and 24 hours, base line and 48 hours, and 24 and 48 hours - after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state Change in maximal voluntary strength between base line and 24 hours, base line and 48 hours, and 24 and 48 hours - after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol
Secondary Outcomes
- change in h-reflex(Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol)
- change in 20:100 hertz force ratio(Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol)
- change in pain pressure threshold in the calf(Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol)
- change in muscle activation(Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol)
- change in the pain visual analog scales(Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol)
- change in the hurt visual analog scales(Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol)
- change in the soreness visual analog scales(Base line then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner in the undamaged state and then 24 and 48 hours after ingesting caffeine/placebo in a counterbalanced manner following damaging protocol)
